Spinal Injectable Market Expected to Reach USD 51.2 Billion by 2033 with a 8.2% of CAGR , Driven by Rising Incidence of Chronic Lower Back Pain

The global spinal injectable market is projected to be valued at US$ 23.3 billion in 2023 and is anticipated to exceed US$ 51.2 billion by 2033, reflecting a robust compound annual growth rate (CAGR) of 8.2% during the forecast period. This accelerated growth can be largely attributed to the exponentially increasing prevalence of chronic lower back pain, which is becoming a significant public health concern worldwide.

Chronic lower back pain affects millions of individuals globally and is a leading cause of disability. As the aging population expands and lifestyle-related factors contribute to the rise in musculoskeletal disorders, the demand for effective pain management solutions, including spinal injectables, is expected to grow significantly. Spinal injectables, such as corticosteroids, anesthetics, and other therapeutic agents, are widely utilized to alleviate pain and inflammation, providing much-needed relief for patients suffering from various spine-related conditions.

Technological advancements in injection techniques and formulations are also contributing to market growth. Innovations in minimally invasive procedures and improved delivery systems enhance the effectiveness and safety of spinal injectables, making them a preferred choice among healthcare professionals.

Other Drivers Propelling the Demand for Spinal Injectable include:

• The key driver driving the market is a rise in the prevalence and awareness of spinal muscular atrophy (SMA). As of January 2021, 39 states, or 86% of all births in the United States, had SMA screening programs.
• The market will be driven by rising demand for minimally invasive treatment procedures. Spinal injectables are a non-surgical alternative to surgical procedures.
• Increasing pain management adoption by lowering systemic opioids. Spinal injectables are important in the treatment of both acute and chronic pain problems, such as surgical pain, cancer-related pain, and chronic back pain.
• In regional anaesthesia procedures such as spinal anaesthesia, spinal injectables are used. These approaches provide safe and dependable anaesthesia while reducing the hazards associated with general anaesthesia.

Challenges for Companies /Manufacturers in the Spinal Injectable Market:

• Risks and consequences associated with spinal injectables include infection, hemorrhage, nerve injury, dural puncture headache, allergic reactions, and medication-related side effects. These negative events may limit their use.
• Spinal injections necessitate specialized knowledge and technical expertise. The scarcity of skilled experts may limit the broad use of spinal injectables.
• Some patients may have concerns or fears regarding spinal injections, which can impact their acceptance and willingness to undergo the procedure.

How Key Players Stay Competitive in the Spinal Injectable Industry?

The spinal injectable industry is highly competitive, with numerous players vying for market share. In such a scenario, key players are adopting effective strategies to stay ahead of the competition.

Key Strategies Adopted by the Players

• Product Innovation

Key players focus on developing and introducing innovative products to address unmet needs in the market. They invest in research and development to improve existing formulations, delivery systems, and enhance the efficacy and safety of the products

• Strategic Partnerships and Collaborations

Key players often form strategic partnerships and collaborations with other companies, research institutes, or healthcare organizations, these partnerships allow for knowledge sharing, joint research and development efforts, and access to complementary technologies or expertise.

• Expansion into Emerging Markets

Key players strive to expand their presence in different geographic regions to tap into new markets and reach a wider customer base. They may establish subsidiaries, distribution networks. Or strategic alliances in various countries to strengthen their market position.

• Mergers and Acquisitions

Companies in the market may engage in mergers or acquisitions to consolidate their product portfolio, acquire new technologies, these strategic moves allow companies to enter new market segments, gain access to novel products or intellectual property, and achieve synergies in terms of research, manufacturing, or distributions.

Key Players in the Spinal Injectable Industry

• SpineCompany Ltd
• Rouzel Pharma Pvt Ltd
• Anant Pharmaceuticals Pvt. Ltd.
• Pfizer Inc.
• Wellona Pharma
• Celon Laboratories Ltd.
• ICI HEALTHCARE PVT. LTD.
• Sun Pharmaceuticals Industries Ltd.
• Inca Healthcare Pvt. Ltd.
• Neon Laboratories Limited
• Nicholas Piramal India Ltd.
• AbbVie
• AstraZeneca
• Hikma Pharmaceuticals PLC

Key Developments in the Spinal Injectable Market:

• May 9, 2023, The United States Food and Drug Administration (FDA) has granted regulatory approval for The Trendlines Group Ltd.’s EpiFinder.

Get Complete Full Report

Segmentation Analysis of the Spinal Injectable Market

By Injection Type:

• Epidural Injection
• Facet Joint Injection
• Sacroiliac Joint Injection
• Trigger Point Injection
• Provocation Discography

By Application:

• Diagnostic
• Therapeutic

By Spinal Region:

• Cervical
• Thoracic
• Lumber

By End User:

• Hospitals
• Specialty Clinics
• Regenerative Sports and Spine Centers
• Diagnostic Centers
• Ambulatory Surgical Centers

By Region:

• North America
• Latin America
• Europe
• East Asia
• South Asia
• Oceania
• The Middle East & Africa

Author By:

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube